Summary
A 45-year-old design engineering manager was denied a security clearance under Guideline E (Personal Conduct) and Guideline H (Drug Involvement). The denial stemmed from the applicant's admitted marijuana use from approximately April 1996 to at least December 2022, and his stated intent to continue using the substance.
Specifically, the applicant failed to disclose his drug involvement in response to section 23 of his 2022 security clearance application, which inquired about illegal drug use. He also used marijuana after completing his application in June 2022. These actions raised disqualifying conditions related to personal conduct and drug involvement.
The judge determined that the applicant's failure to disclose his ongoing marijuana use and his expressed intent to continue using it demonstrated significant concerns regarding his reliability and trustworthiness. No mitigating conditions were established to address these concerns, leading to the denial of his security clearance application.
Why the Applicant Was Denied
- The applicant admitted to marijuana use from 1996 to 2022 and expressed intent to continue using it.
- The applicant failed to disclose his marijuana use during his initial background interview and marked 'No' on his security clearance application regarding illegal drug use.
- The judge found that the applicant did not establish any mitigating conditions to address the concerns raised by his drug involvement and personal conduct.
Conditions Referenced
- AG ¶ 25(a)appliedSubstance Misuse
- AG ¶ 25(c)appliedIllegal Possession of a Controlled Substance
- AG ¶ 25(g)appliedIntent to Continue Drug Involvement
- AG ¶ 16(a)appliedDeliberate Omission
Procedural Posture
- SOR issuedJan 26, 2023
- Answer filedFeb 25, 2023Applicant elected for a written record decision.
- Hearing held—Decision made based on written record.
- Decision dateDec 5, 2023
Cite For
- Failure to Disclose Drug Use on Security Clearance Application Under Guideline E
- Ongoing Drug Involvement as a Disqualifying Condition Under Guideline H
- Lack of Mitigating Conditions for Drug Involvement and Personal Conduct Issues